---
title: IPNA consensus definitions for clinical trial outcomes in steroid-resistant
  nephrotic syndrome
date: '2024-10-09'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39384644/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20241010184200&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Assessment of the true impact of therapeutic interventions is a challenge
  in the absence of universal, standardized definitions for clinical trial endpoints
  in children with kidney diseases. Steroid-resistant nephrotic syndrome (SRNS) is
  a difficult kidney disease to treat, with unremitting disease progressing to kidney
  failure. Currently, available therapies result in suboptimal cure rates. Clinical
  trials with innovative, targeted treatments will likely be conducted for this disease
  in ...
disable_comments: true
---
Assessment of the true impact of therapeutic interventions is a challenge in the absence of universal, standardized definitions for clinical trial endpoints in children with kidney diseases. Steroid-resistant nephrotic syndrome (SRNS) is a difficult kidney disease to treat, with unremitting disease progressing to kidney failure. Currently, available therapies result in suboptimal cure rates. Clinical trials with innovative, targeted treatments will likely be conducted for this disease in ...